Phase II study of S-1 and irinotecan combination chemotherapy as a first-line therapy for patients with advanced gastric cancer. Korean Cancer Study Group Protocol ST05-02
- Hye J. Kang
- , Sang H. Cho
- , Suk J. Oh
- , Sung H. Yang
- , Moon H. Lee
- , Eun Kee Song
- , Hyun C. Chung
- , Im I. Na
- , Baek Yeol Ryoo*
*Corresponding author for this work
- Korea Institute of Radiological and Medical Sciences
- Chonnam National University
- Kangbuk Samsung Hospital
- Inha University
- Yonsei University
Research output: Contribution to journal › Journal article › peer-review
5
Link opens in a new tab
Scopus
citations